PLC Systems finishes heart laser study:
This article was originally published in Clinica
PLC Systems has finished collecting data from the last TMR patients in its study of its Heart Laser System. The US company is expecting to submit the report to the FDA in November. The Heart Laser System is a high-powered computer controlled carbon dioxide laser and is used in TMR for creating channels in oxygen-deprived heart muscle of patients suffering coronary artery disease.
You may also be interested in...
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from India's Glenmark.
Second read-out maintains 94% level of efficacy, with a very early signal that it could outperform Pfizer’s rival mRNA candidate in preventing severe cases.
The French major and Regeneron have racked up another indication for Dupixent with the blockbuster getting approval in Europe to treat children with severe eczema.